A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising...
Gespeichert in:
| Veröffentlicht in: | International journal of molecular sciences 2023-03, Vol.24 (7), p.6369 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | 6369 |
| container_title | International journal of molecular sciences |
| container_volume | 24 |
| creator | Luo, Junhao Zhang, Zhuohan Zhao, Song Gao, Rongbao |
| description | Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising a global pandemic which has persisted in the world for almost three years. Influenza virus, a seasonally circulating respiratory pathogen, has caused four global pandemics in humans since 1918 by the emergence of novel variants. Studies have shown that there are certain similarities in transmission mode and pathogenesis between influenza and COVID-19, and vaccination and antiviral drugs are considered to have positive roles as well as several limitations in the prevention and control of both diseases. Comparative understandings would be helpful to the prevention and control of these diseases. Here, we review the study progress in the etiology, pathogenesis, vaccine and antiviral drug development for the two diseases. |
| doi_str_mv | 10.3390/ijms24076369 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10094131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751927382</galeid><sourcerecordid>A751927382</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-d07ce18d4ea7c43f5767e59253e80f725dfced8d27d933028fac9d8fc7f6bee93</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEog_YsUaW2LCYtH4ksb1Co5mWjlSpLKBby2Nfpx4l9hAng8qvx6UPpqjywq_vHF8f3aL4QPAJYxKf-k2faIV5wxr5qjgkFaUlxg1_vbc-KI5S2mBMGa3l2-KAcVzxrD4swhwtYr_Vg08xoOjQ2ehjF9vbGfqmx5vYQoDk0wxda2N80B3SwaJ5GP3OD3m3HKYWLWEHXdz2EEa0hvEXQECr4LoJwm_9V7C4ul4tSyLfFW-c7hK8f5iPix_nZ98XF-Xl1dfVYn5ZmkrgsbSYGyDCVqC5qZirecOhlrRmILDjtLbOgBWWcisZw1Q4baQVznDXrAEkOy6-3Ptup3UP1uTKcrVqO_heD7cqaq-e3wR_o9q4UwRjWRFGssPnB4ch_pwgjar3yUDX6QBxSoqKHCwlHDcZ_fQfuonTkLPKFJeyEXVN-D-q1R0oH1zMD5s7UzXnNZGUM0EzdfIClYeF3psYwPl8_kwwuxeYIaY0gHv6JMHqrkHUfoNk_ON-ME_wY0ewPwnwtd4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799685517</pqid></control><display><type>article</type><title>A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Luo, Junhao ; Zhang, Zhuohan ; Zhao, Song ; Gao, Rongbao</creator><creatorcontrib>Luo, Junhao ; Zhang, Zhuohan ; Zhao, Song ; Gao, Rongbao</creatorcontrib><description>Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising a global pandemic which has persisted in the world for almost three years. Influenza virus, a seasonally circulating respiratory pathogen, has caused four global pandemics in humans since 1918 by the emergence of novel variants. Studies have shown that there are certain similarities in transmission mode and pathogenesis between influenza and COVID-19, and vaccination and antiviral drugs are considered to have positive roles as well as several limitations in the prevention and control of both diseases. Comparative understandings would be helpful to the prevention and control of these diseases. Here, we review the study progress in the etiology, pathogenesis, vaccine and antiviral drug development for the two diseases.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms24076369</identifier><identifier>PMID: 37047339</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antiviral agents ; Antiviral Agents - pharmacology ; Antiviral Agents - therapeutic use ; Antiviral drugs ; Causes and theories of causation ; China ; Comparative analysis ; Coronaviruses ; COVID-19 ; Development and progression ; Diseases ; Drug Development ; Epidemics ; Etiology ; Health aspects ; Humans ; Influenza ; Influenza Vaccines ; Influenza, Human - drug therapy ; Influenza, Human - prevention & control ; Lung diseases ; Mutation ; Pandemics ; Pathogenesis ; Pathogens ; Respiratory tract diseases ; Respiratory Tract Infections - drug therapy ; Review ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; United Kingdom ; Vaccination ; Viruses</subject><ispartof>International journal of molecular sciences, 2023-03, Vol.24 (7), p.6369</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-d07ce18d4ea7c43f5767e59253e80f725dfced8d27d933028fac9d8fc7f6bee93</citedby><cites>FETCH-LOGICAL-c480t-d07ce18d4ea7c43f5767e59253e80f725dfced8d27d933028fac9d8fc7f6bee93</cites><orcidid>0000-0003-0137-4365</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094131/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094131/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37047339$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luo, Junhao</creatorcontrib><creatorcontrib>Zhang, Zhuohan</creatorcontrib><creatorcontrib>Zhao, Song</creatorcontrib><creatorcontrib>Gao, Rongbao</creatorcontrib><title>A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising a global pandemic which has persisted in the world for almost three years. Influenza virus, a seasonally circulating respiratory pathogen, has caused four global pandemics in humans since 1918 by the emergence of novel variants. Studies have shown that there are certain similarities in transmission mode and pathogenesis between influenza and COVID-19, and vaccination and antiviral drugs are considered to have positive roles as well as several limitations in the prevention and control of both diseases. Comparative understandings would be helpful to the prevention and control of these diseases. Here, we review the study progress in the etiology, pathogenesis, vaccine and antiviral drug development for the two diseases.</description><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Antiviral drugs</subject><subject>Causes and theories of causation</subject><subject>China</subject><subject>Comparative analysis</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Development and progression</subject><subject>Diseases</subject><subject>Drug Development</subject><subject>Epidemics</subject><subject>Etiology</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Influenza</subject><subject>Influenza Vaccines</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - prevention & control</subject><subject>Lung diseases</subject><subject>Mutation</subject><subject>Pandemics</subject><subject>Pathogenesis</subject><subject>Pathogens</subject><subject>Respiratory tract diseases</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Review</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>United Kingdom</subject><subject>Vaccination</subject><subject>Viruses</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkktv1DAUhSMEog_YsUaW2LCYtH4ksb1Co5mWjlSpLKBby2Nfpx4l9hAng8qvx6UPpqjywq_vHF8f3aL4QPAJYxKf-k2faIV5wxr5qjgkFaUlxg1_vbc-KI5S2mBMGa3l2-KAcVzxrD4swhwtYr_Vg08xoOjQ2ehjF9vbGfqmx5vYQoDk0wxda2N80B3SwaJ5GP3OD3m3HKYWLWEHXdz2EEa0hvEXQECr4LoJwm_9V7C4ul4tSyLfFW-c7hK8f5iPix_nZ98XF-Xl1dfVYn5ZmkrgsbSYGyDCVqC5qZirecOhlrRmILDjtLbOgBWWcisZw1Q4baQVznDXrAEkOy6-3Ptup3UP1uTKcrVqO_heD7cqaq-e3wR_o9q4UwRjWRFGssPnB4ch_pwgjar3yUDX6QBxSoqKHCwlHDcZ_fQfuonTkLPKFJeyEXVN-D-q1R0oH1zMD5s7UzXnNZGUM0EzdfIClYeF3psYwPl8_kwwuxeYIaY0gHv6JMHqrkHUfoNk_ON-ME_wY0ewPwnwtd4</recordid><startdate>20230328</startdate><enddate>20230328</enddate><creator>Luo, Junhao</creator><creator>Zhang, Zhuohan</creator><creator>Zhao, Song</creator><creator>Gao, Rongbao</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0137-4365</orcidid></search><sort><creationdate>20230328</creationdate><title>A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19</title><author>Luo, Junhao ; Zhang, Zhuohan ; Zhao, Song ; Gao, Rongbao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-d07ce18d4ea7c43f5767e59253e80f725dfced8d27d933028fac9d8fc7f6bee93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Antiviral drugs</topic><topic>Causes and theories of causation</topic><topic>China</topic><topic>Comparative analysis</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Development and progression</topic><topic>Diseases</topic><topic>Drug Development</topic><topic>Epidemics</topic><topic>Etiology</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Influenza</topic><topic>Influenza Vaccines</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - prevention & control</topic><topic>Lung diseases</topic><topic>Mutation</topic><topic>Pandemics</topic><topic>Pathogenesis</topic><topic>Pathogens</topic><topic>Respiratory tract diseases</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Review</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>United Kingdom</topic><topic>Vaccination</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luo, Junhao</creatorcontrib><creatorcontrib>Zhang, Zhuohan</creatorcontrib><creatorcontrib>Zhao, Song</creatorcontrib><creatorcontrib>Gao, Rongbao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luo, Junhao</au><au>Zhang, Zhuohan</au><au>Zhao, Song</au><au>Gao, Rongbao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-03-28</date><risdate>2023</risdate><volume>24</volume><issue>7</issue><spage>6369</spage><pages>6369-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising a global pandemic which has persisted in the world for almost three years. Influenza virus, a seasonally circulating respiratory pathogen, has caused four global pandemics in humans since 1918 by the emergence of novel variants. Studies have shown that there are certain similarities in transmission mode and pathogenesis between influenza and COVID-19, and vaccination and antiviral drugs are considered to have positive roles as well as several limitations in the prevention and control of both diseases. Comparative understandings would be helpful to the prevention and control of these diseases. Here, we review the study progress in the etiology, pathogenesis, vaccine and antiviral drug development for the two diseases.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37047339</pmid><doi>10.3390/ijms24076369</doi><orcidid>https://orcid.org/0000-0003-0137-4365</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2023-03, Vol.24 (7), p.6369 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10094131 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Antiviral agents Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Antiviral drugs Causes and theories of causation China Comparative analysis Coronaviruses COVID-19 Development and progression Diseases Drug Development Epidemics Etiology Health aspects Humans Influenza Influenza Vaccines Influenza, Human - drug therapy Influenza, Human - prevention & control Lung diseases Mutation Pandemics Pathogenesis Pathogens Respiratory tract diseases Respiratory Tract Infections - drug therapy Review SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 United Kingdom Vaccination Viruses |
| title | A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T11%3A50%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Comparison%20of%20Etiology,%20Pathogenesis,%20Vaccinal%20and%20Antiviral%20Drug%20Development%20between%20Influenza%20and%20COVID-19&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Luo,%20Junhao&rft.date=2023-03-28&rft.volume=24&rft.issue=7&rft.spage=6369&rft.pages=6369-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms24076369&rft_dat=%3Cgale_pubme%3EA751927382%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2799685517&rft_id=info:pmid/37047339&rft_galeid=A751927382&rfr_iscdi=true |